ICU sedation, delirium & recovery

Epidemiology of pain, delirium, psychiatric disorders, discomfort and sedation-analgesia management in the intensive care unit: a one-day nationwide study

Crit CarePublished Cross-sectional study

Authors' conclusion

The shift toward lighter sedation has been successfully achieved; however, a broad spectrum of stressful symptoms persists, including pain, anxiety, thirst, and sleep disruption.

Study context

Population
Adult patients hospitalised in French intensive care units (ICUs) on the study day
Participants
2,063 patients · 128 ICUs
Outcome
Sedation-analgesia management and discomfort
Methodological detailsone-day, multicentre, nationwide
  • One-day
  • Multicentre
  • Nationwide

Main finding

As reported in the abstract

Light or no sedation
84%
Deeply sedated
15%
Deep sedation misaligned with usual indications (of deeply sedated)
63%
Pain assessed at rest
90%
Pain assessed during care
62%
Hypnotics used, mainly propofol and midazolam
31%
Discomfort reported, mainly anxiety, sleep disorders and thirst
44%

Observational data: associations, not effects.

Further findings

ICU characteristics

University-affiliated ICUs
54%
Mixed medical-surgical ICUs
58%
Written sedation-analgesia protocol
63%
ICUs assessing sedation
96%
ICUs assessing pain
91%

Associations (multilevel logistic regression)

Higher SOFA scores associated with deep or misaligned deep sedation
Written protocol reduced risk of unassessed pain, not associated with deep or misaligned deep sedation
Written protocol not associated with sedation depth, drug use or delirium screening; linked to more frequent pain assessment at rest

Original publication

Epidemiology of pain, delirium, psychiatric disorders, discomfort and sedation-analgesia management in the intensive care unit: a one-day nationwide study. Crit Care. Published 11 November 2025. doi:10.1186/s13054-025-05654-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.